Asset Allocation

As of November 30, 2025.
Type % Net
Cash 13.13%
Stock 65.74%
Bond 19.27%
Convertible 0.00%
Preferred 0.00%
Other 1.87%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 80.34%    % Emerging Markets: 5.64%    % Unidentified Markets: 14.03%

Americas 54.37%
50.29%
Canada 3.28%
United States 47.01%
4.09%
Brazil 0.85%
Mexico 1.69%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 12.47%
United Kingdom 2.23%
10.24%
Denmark 2.29%
France 4.92%
Ireland 1.75%
Italy 1.27%
0.00%
0.00%
Greater Asia 19.13%
Japan 6.98%
3.01%
Australia 3.01%
6.15%
Hong Kong 2.34%
South Korea 3.81%
2.99%
China 0.80%
India 2.19%
Unidentified Region 14.03%

Bond Credit Quality Exposure

AAA 0.00%
AA 23.13%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 76.87%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
30.69%
Materials
12.26%
Consumer Discretionary
3.68%
Financials
14.74%
Real Estate
0.00%
Sensitive
28.47%
Communication Services
9.26%
Energy
7.67%
Industrials
5.52%
Information Technology
6.02%
Defensive
9.45%
Consumer Staples
2.99%
Health Care
6.43%
Utilities
0.02%
Not Classified
31.40%
Non Classified Equity
0.00%
Not Classified - Non Equity
31.40%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 98.15%
Corporate 0.00%
Securitized 0.00%
Municipal 0.00%
Other 1.85%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
91.93%
Less than 1 Year
91.93%
Intermediate
8.07%
1 to 3 Years
8.07%
3 to 5 Years
0.00%
5 to 10 Years
0.00%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial